Klotho in Chronic Kidney Disease-associated Pruritis (CKD-aP)

NCT03532568 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-05-22

No results posted yet for this study

Summary

Studying whether Klotho and FGF23 have a role in UP and whether their expression change by BB-UVB with the improvement of pruritus.

Conditions

  • Chronic Kidney Disease-associated Pruritus

Interventions

OTHER

skin biopsy

4mm punch skin biopsy

RADIATION

narrowband ultraviolet B

narrowband ultraviolet B for CKD-aP patients

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-31
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03532568 on ClinicalTrials.gov